arrow
返回
R

Ray McDermott

Cancer Trials Ireland

62H指数
491论文数
3.8W被引数
收录论文 110
发表时间
Pembrolizumab Plus Lenvatinib in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort E帕博利珠单抗联合仑伐替尼在多西他赛预处理的转移性去势抵抗性前列腺癌患者中的疗效:KEYNOTE-365研究E组的初步结果
err2026-05-02
err0
PREAI
errMarinela Augustin; Brigitte Laguerre; Capucine Baldini; Ahmed H. Zedan; Enrique Gonzalez-Billalabeitia; Peter C. Fong; Ruslan Zukov; Peter Hammerer; Mark Prentice; Neal Shore; Andrea Necchi; Tilman Todenhöfer; Elizabeth R. Kessler; Fatih Kose; Howard Gurney; Begona P. Valderrama; Pengfei Zhu; Kentaro Imai; Yingjie Liu; Ray McDermott
err分享
err收藏
Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer炎症和突变负担与nivolumab或ipilimumab联合疗法的疗效在结直肠癌中存在差异关联。
err2025-10-06
err0
errOAAI
errMing Lei; Michael J. Overman; Jin Yao; Thierry André; Sara Lonardi; Heinz-Josef Lenz; Massimo Aglietta; Fabio Gelsomino; Ray McDermott; Ka Yeung Mark Wong; Michael A. Morse; Eric Van Cutsem; Alain Hendlisz; Dana B. Cardin; Bart Neyns; Andrew Hill; Anuradha Krishnamurthy; Franklin Chen; Samith Kochuparambil; Robert R. Jenq; Sandzhar Abdullaev; Beilei He; Ruslan Novosiadly; Scott Kopetz
err分享
err收藏
Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial调整阿比特龙-泼尼松交叉对原发转移性去势敏感前列腺癌的影响:PEACE-1试验的事后分析
err2025-09-27
err0
PREAI
errAdrien Rousseau; Maryam Karimi; Stefan Michiels; Guilhem Roubaud; Xavier Maldonado; Stephane Supiot; Ray McDermott; Aude Flechon; Bertrand Tombal; Philippe Ronchin; Dominik Berthold; Jean-François Berdah; Gabriel Kacso; Gwenaelle Gravis; Fabio Calabro; Sophie Tartas; Xavier Muracciole; Helene Ribault; Karim Fizazi; Stéphanie Foulon
err分享
err收藏
Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate CancerKEYLYNK-010研究中患者报告结局:帕博利珠单抗联合奥拉帕利与阿比特龙或恩扎卢胺治疗生物标志物未筛选、既往接受过治疗的转移性去势抵抗性前列腺癌患者
err2025-07-19
err0
errOAAI
errNiven Mehra; Emmanuel S. Antonarakis; Se Hoon Park; Jeffrey C. Goh; Ray McDermott; Nuria Sala Gonzalez; Peter C. Fong; Richard Greil; Maria De Santis; Patricio Eduardo Yanez; Yi-Hsiu Huang; Stephen D. Begbie; Felipe Rey; Gero Kramer; Hiroyoshi Suzuki; Todd L. Saretsky; Sameer R. Ghate; Yi Cui; Christian Hosius; Evan Y. Yu
err分享
err收藏
Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer拉罗替尼作为TRK融合癌患者一线治疗的疗效与安全性
err2025-06-01
err0
PREAI
errD.S. Hong; R.-H. Xu; L. Shen; M.P. Dierselhuis; D. Orbach; R. McDermott; A. Italiano; M. Tahara; V. Bernard-Gauthier; N. Neu; C.E. Mussi; E. De La Cuesta; T.W. Laetsch; A. Drilon
err分享
err收藏
Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial恩扎卢替胺联合镭-223治疗转移性去势抵抗性前列腺癌:EORTC 1333/PEACE-3试验结果
err2025-05-30
err0
errOAAI
errB. Tombal; A. Choudhury; F. Saad; E. Gallardo; A. Soares; Y. Loriot; R. McDermott; A. Rodriguez-Vida; P. Isaacsson Velho; F. Nolè; F. Cruz; T. Roumeguere; G. Daugaard; R. Yamamura; E. Bompas; P. Maroto; F. Gomez Veiga; I. Skoneczna; K. Martins da Trindade; F. Mavignier Carcano; F. Lecouvet; C. Coens; C. Poncet; B. Fournier; S. Gillessen
err分享
err收藏
Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)循环脂质面板PCPro与转移性激素敏感前列腺癌临床结局的关联:ENZAMET III期随机试验(ANZUP 1304)的事后分析
err2025-05-20
err0
PREAI
errH.-M. Lin; T. Scheinberg; N. Portman; R.M.N. Kim; R. Mellor; K. Huynh; A.N. Faulkner; N.A. Mellett; I.D. Davis; A. Martin; D. Sullivan; A. Joshua; M. McJannett; V. Subhash; S. Yip; A.A. Azad; I.C. Marschner; S.A. North; R.S. McDermott; K.N. Chi; M.R. Stockler; C.J. Sweeney; P.J. Meikle; L.G. Horvath
err分享
err收藏
Are we there yet? Closing the gap of prostate cancer presentation disparities in Ireland我们到那儿了吗?缩小爱尔兰前列腺癌表现差异的差距
err2024-11-13
err0
errOAAI
errGordon, Noa; Dooley, Cara; Murphy, Aine; Glynn, Sharon; Sharp, Linda; Sullivan, Frank; McDermott, Ray; Watson, William; Galvin, David
err分享
err收藏
Long-term efficacy and safety of larotrectinib in non-primary central nervous system (CNS) TRK fusion cancer拉罗替尼在非原发性中枢神经系统(CNS)TRK融合癌中的长期疗效和安全性
err2024-09-01
err0
PREAI
errDrilon, A. E.; Xu, R-H.; van Tilburg, C. M.; Doz, F.; Tan, D. S. W.; Lin, J. J.; Geoerger, B.; Zwaan, C. M.; Lassen, U. N.; Italiano, A.; Kummar, S.; McDermott, R. S.; Burcoveanu, D-I.; Neu, N.; Brega, N.; Laetsch, T.; Hong, D. S.; Shen, L.
err分享
err收藏
Efficacy and safety of larotrectinib as first-line treatment for patients (pts) with TRK fusion cancer: An updated analysis拉罗替尼作为携带TRK融合癌患者(pts)一线治疗的疗效与安全性:一项更新分析
err2024-09-01
err0
PREAI
errHong, D. S.; Xu, R-H.; Shen, L.; Dierselhuis, M. P.; Orbach, D.; McDermott, R. S.; Italiano, A.; Tahara, M.; Bernard-Gauthier, V.; Neu, N.; Mussi, C. E.; De La Cuesta, E. A.; Laetsch, T.; Drilon, A. E.
err分享
err收藏
Association of the lipid biomarker, PCPro, and clinical outcomes in the ENZAMET trial (ANZUP 1304)脂质生物标志物PCPro与临床结局的关联:ENZAMET试验(ANZUP 1304)
err2024-09-01
err0
PREAI
errHorvath, L. G.; Lin, H-M.; Davis, I. D.; Martin, A.; Scheinberg, T.; Meikle, P.; Joshua, A.; Mcjannett, M.; Subhash, V.; Yip, S.; North, S.; McDermott, R. S.; Chi, K. N.; Stockler, M. R.; Sweeney, C.
err分享
err收藏
Clinical prognostic factors within the high volume subgroup of metastatic hormone sensitive prostate cancer (mHSPC) in ENZAMET (ANZUP 1304)ENZAMET(ANZUP 1304)研究中,转移性激素敏感性前列腺癌(mHSPC)高容量亚组内的临床预后因素
err2024-09-01
err0
PREAI
errHamid, A. A.; Thomas, H.; Martin, A.; Soon, Y. Y.; Horvath, L. G.; Zielinski, R.; Thomson, A.; Tan, H.; Sandhu, S. K.; Reaume, M. N.; Pook, D. W.; Parnis, F.; McDermott, R. S.; Lawrence, N.; Frydenberg, M.; Chi, K. N.; Stockler, M. R.; Davis, I. D.; Sweeney, C.
err分享
err收藏
Genomic and Transcriptomic Analysis of a Patient with Early-Onset Colorectal Cancer and Therapy-Induced Focal Nodular Hyperplasia: A Case Report
err2024-06-15
err0
errOAAI
errO'Reilly, Mary; Krstic, Aleksandar; Iglesias-Martinez, Luis F.; Ryan, Eanna J.; Moran, Bruce; Winter, Des; Sheahan, Kieran; McDermott, Ray; Kolch, Walter
err分享
err收藏
Switching to S-1-based adjuvant treatment is feasible in colorectal cancer patients after cardiotoxicity on fluoropyrimidine-based treatment: A retrospective multicentre observational study
err2024-06-01
err0
PREAI
errOsterlund, P. J.; Kinos, S.; Halonen, P.; Soveri, L-M.; Heerva, E.; Algars, A.; Ristamaki, R.; Salminen, T.; O'Reilly, M. O.; McDermott, R. S.; Kallio, R.; Rockert, R.; Flygare, P.; Froedin, J-E.; Glimelius, B.
err分享
err收藏